Search results (24)
« Back to News & EventsOxford researchers develop blood test to enable early detection of multiple cancers
8 January 2025
Oxford University researchers have unveiled a new blood test – powered by machine learning – which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.
Oxford Centre for Cancer Early Detection and Prevention celebrates 5 years at its 2024 Symposium
3 January 2025
On 10-11th December, we celebrated 5 years since the launch of OxCODE with a showcase of Oxford’s most successful cancer early detection and prevention programmes.
OxCODE researchers at the Early Detection of Cancer Conference 2024
25 October 2024
Oxford’s early detection research was featured at this annual event.
OxCODE travel awards 2024
20 June 2024
Congratulations to Jingfei Cheng, Holly Eggington, Yi-Jhih Huang, Zhe Huang and Joshua Moore who have been awarded OxCODE funds to attend this year’s major cancer prevention and early detection conferences.
Oxford Centre for Early Cancer Detection Symposium 2023 – a recap
14 December 2023
On Tuesday 5th December, the Oxford early cancer detection community gathered at the Mathematical Institute in Oxford to hear some highlights from OxCODE’s research in the past year and to discuss ideas for future projects.
OxCODE researchers at the Early Detection of Cancer Conference 2023
31 October 2023
Oxford’s early detection research was featured at this annual event.
OxCODE travel awards 2023
25 September 2023
Congratulations to James Chettle, Masato Inoue and Eoghan Mulholland who have been awarded OxCODE funds to attend this year’s Early Detection of Cancer conference in London.
OxCODE researchers at the Early Detection of Cancer Conference 2022
31 October 2022
Oxford’s early detection research was featured at this annual event.
Oxford Centre for Early Cancer Detection Symposium 2022 – a recap
4 October 2022
On Tuesday 13th September, the Oxford early cancer detection community gathered at Worcester College to discuss the latest developments in this field, sparking ideas and collaborations for future research.
Cancer at Oxford
29 September 2022
Read about how Oxford's experts are leading the way in cancer prevention, detection and treatment as part of the University's Cancer at Oxford series
First DeLIVER study day
14 June 2022
On Wednesday 8th June 2022, the DeLIVER consortium gathered for the first time to hear about the team’s progress towards the aim of detecting liver cancer earlier.
National clinical study launched to test new technologies for detecting liver cancer
25 May 2022
The SELINA study will recruit patients with early liver cancers as part of the DeLIVER programme aiming to detect liver cancer earlier.
First major UK prospective study for liver cancer underway
24 February 2022
The Pearl clinical study will recruit 3000 patients with high-risk conditions for liver cancer with the aim of detecting liver cancer earlier as part of the Cancer Research UK-funded DeLIVER programme.
MP Anneliese Dodds tours Oxford cancer research
26 November 2021
Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful cancer research happening across departments, including the work of OxCODE members.
TAPS for cancer detection
1 September 2021
TAPS technology has been optimised for mapping DNA methylation on circulating cell-free DNA.
Ludwig-Oxford Symposium on Cancer Early Detection and Epigenetics – a recap
7 May 2021
On 28-29th April 2021, we heard the latest developments from international leaders in these fields from the University of Oxford, Ludwig Cancer Research and beyond.
New method for cost-effective genome-wide DNA methylation analysis
28 April 2021
Dr Chunxiao Song’s team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.
Developing a system to simultaneously detect genetic and epigenetic information
2 March 2021
Dr Benjamin Schuster-Böckler wins funding to develop algorithms that can identify both genetic variation and DNA methylation from the same sequencing data, with applications in biomedical research and detection of diseases such as cancer.
$410 million buy out for Oxford cancer detection technology
30 October 2020
Oxford spin-out Base Genomics is acquired by early cancer detection company Exact Sciences.
Oxford-developed DNA methylation technology forms the basis of new startup company
3 June 2020
Biotechnology company, Base Genomics, has launched based on Dr Chunxiao Song’s innovative TAPS technology.